Inventor · disambiguated record
Lourdes Salvador Oden
Also filed as: ODEN LOURDES · ODEN LOURDES SALVADOR · ODÉN LOURDES SALVADOR
17 granted patents·4 pending applications·45 citations·filing 2002–2022
92Inventor score
Top patents by PatentIndex Score
21 records- 0186US9200006B2Protease inhibitorsMEDIVIR AB·Filed 2014·Granted Dec 1, 2015·5 cites·8 claims
- 0286US8735395B2Protease inhibitorsMEDIVIR AB·Filed 2013·Granted May 27, 2014·5 cites·12 claims
- 0386US8242119B2Protease inhibitorsODEN LOURDES SALVADOR·Filed 2009·Granted Aug 14, 2012·6 cites·24 claims
- 0486US7893067B2Cysteine protease inhibitorsMEDIVIR AB·Filed 2008·Granted Feb 22, 2011·8 cites·9 claims
- 0585US8198283B2Cysteine protease inhibitorsNILSSON MAGNUS·Filed 2011·Granted Jun 12, 2012·7 cites·10 claims
- 0684US8426421B2Protease inhibitorsODEN LOURDES SALVADOR·Filed 2012·Granted Apr 23, 2013·5 cites·12 claims
- 0783US12378209B2Protease inhibitorsMEDIVIR AB·Filed 2022·Granted Aug 5, 2025·0 cites·1 claims
- 0883US10723709B2Protease inhibitorsMEDIVIR AB·Filed 2019·Granted Jul 28, 2020·1 cites·18 claims
- 0983US8466158B2Cysteine protease inhibitorsNILSSON MAGNUS·Filed 2012·Granted Jun 18, 2013·5 cites·2 claims
- 1073US11312693B2Protease inhibitorsMEDIVIR AB·Filed 2020·Granted Apr 26, 2022·0 cites·3 claims
- 1171US10329266B2Protease inhibitorsMEDIVIR AB·Filed 2018·Granted Jun 25, 2019·0 cites·2 claims
- 1268US6716850B2Non-nucleoside reverse transcriptase inhibitorsMEDIVIR AB·Filed 2002·Granted Apr 6, 2004·2 cites·34 claims
- 1367US7915300B2Cysteine protease inhibitorsMEDIVIR AB·Filed 2005·Granted Mar 29, 2011·1 cites·29 claims
- 1466US2017334867A1Protease inhibitorsMEDIVIR AB·Filed 2017·Application pending·0 cites
- 1564US9428517B2Protease inhibitorsMEDIVIR AB·Filed 2015·Granted Aug 30, 2016·0 cites·4 claims
- 1664US2017166538A1Protease inhibitorsMEDIVIR AB·Filed 2016·Application pending·0 cites
- 1755US7405310B2Non-nucleoside reverse transcriptase inhibitorsMEDIVIR AB·Filed 2005·Granted Jul 29, 2008·0 cites·5 claims
- 1848US9650388B2Form 2 crystalline polymorph of a salt of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-B]pyrrole-4-carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazinyl) thiazol-4-yl]-benzamide useful as cysteine protease inhibitorMEDIVIR AB·Filed 2014·Granted May 16, 2017·0 cites·24 claims
- 1948US6894177B2Intermediate compounds of non-nucleoside reverse transcriptase inhibitorsMEDIVIR AB·Filed 2003·Granted May 17, 2005·0 cites·14 claims
- 2040US2011112089A1Cysteine Protease InhibitorsMEDIVIR AB·Filed 2011·Application pending·0 cites
- 2132US2019002436A1Respiratory syncytial virus inhibitorsMEDIVIR AB·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lourdes Salvador Oden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →